Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Interventional × Neck Dissection × Clear all

Phase

Phase 2 5 Phase NA 4 Phase 2/3 2 Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Squamous Cell 1

Interventions

Cyclophosphamide 565 pembrolizumab 437 Paclitaxel 400 Gemcitabine 387 Cisplatin 383 Carboplatin 381 Radiotherapy 343 fludarabine 321 Nivolumab 300 Bevacizumab 250 Docetaxel 242 Irinotecan 225 Magnetic Resonance Spectroscopy 216 Dexamethasone 201 Fluorouracil 200 Specimen Handling 196 Capecitabine 195 Cytarabine 183 Rituximab 182 Oxaliplatin 180 Temozolomide 177 fludarabine phosphate 174 Biopsy 174 Ipilimumab 167 Etoposide 165 Lenalidomide 162 Doxorubicin 153 Cetuximab 153 Leucovorin 151 Bortezomib 150

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02269020 2019-01-11

RoboCurage ORL

Centre Hospitalier Universitaire de Nīmes

Phase 1 Completed

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡